Two recent uncontrolled studies have examined the efficacy of parenteral methotrexate in fistulizing CD. In the first, treatment with intramuscular methotrexate (25 mg/week), in 16 patients produced fistula closure in 4 and a partial response in 5, with an overall response of 56%. All the patients who achieved remission failed or were intolerant to AZA and 25% also failed to respond to CyA. However, fistulae recurred when methotrexate was reduced or was switched to an oral form . In the second, a study of 20 patients with active CD who were AZA-resistant or intolerant and steroid dependent (8 with a fistula), a response was obtained in 14/20 at 12 weeks, in 10/20 at 6 months, and 4/14 at 12 months. Patients with fistulizing disease were not analyzed separately . Adverse events have been reported in 50% of patients treated with parenteral methotrexate for more than 6 months and include elevation of transaminases (5-20% of patients), nausea (4-12%), bone marrow suppression (10-20%), and require discontinuation of the drug in 10% of patients .
Hepatic fibrosis was observed in 0-5% of patients who have undergone liver biopsy after a cumulative methotrexate dose of more than 1 500 mg . A potentially life-threatening interstitial pneumonitis has been observed in 3-12% of long-term treated patients. Furthermore, methotrexate has a known toxicity on the fetus. In conclusion, MTX in a dose of 25 mg/week should be tried in AZA/6-mercaptop-urine resistant or intolerant patients.
Was this article helpful?
Moles, warts, and other unsightly irregularities of the skin can be bothersome and even embarrassing. They can be removed naturally... Removing Warts and Moles Naturally! If you have moles, warts, and other skin irregularities that you cannot cover up affecting the way you look, you can have them removed. Doctors can be extremely expensive. Learn the natural ways you can remove these irregularities in the comfort of your own home.